Literature DB >> 12667826

Antenatal factors and the development of bronchopulmonary dysplasia.

Alan H Jobe1.   

Abstract

The lung of the preterm fetus is often exposed to antenatal glucocorticoids, and histologic chorioamnionitis is frequent. Clinically and experimentally, antenatal glucocorticoids and/or chorioamnionitis are associated with early lung maturation, but in experimental models, both glucocorticoids and intra-uterine inflammation decrease alveolarization. Experimental chorioamnionitis also can amplify the inflammatory response of the preterm lung to mechanical ventilation. In this article, the hypothesis developed is that bronchopulmonary dysplasia occurs because of repetitive adverse lung exposures, or hits, and that the initial hits may be antenatal glucocorticoid exposure and/or antenatal inflammation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12667826     DOI: 10.1016/s1084-2756(02)00188-4

Source DB:  PubMed          Journal:  Semin Neonatol        ISSN: 1084-2756


  32 in total

1.  Benefit of antenatal glucocorticoids according to the cause of very premature birth.

Authors:  L Foix-L'helias; O Baud; R Lenclen; M Kaminski; T Lacaze-Masmonteil
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-01       Impact factor: 5.747

Review 2.  The role of inflammation and infection in preterm birth.

Authors:  Roberto Romero; Jimmy Espinoza; Luís F Gonçalves; Juan Pedro Kusanovic; Lara Friel; Sonia Hassan
Journal:  Semin Reprod Med       Date:  2007-01       Impact factor: 1.303

Review 3.  Management of bronchopulmonary dysplasia in infants: guidelines for corticosteroid use.

Authors:  David G Grier; Henry L Halliday
Journal:  Drugs       Date:  2005       Impact factor: 9.546

4.  Chorioamnionitis with or without funisitis increases the risk of hypotension in very low birthweight infants on the first postnatal day but not later.

Authors:  S Y R Lee; D K Ng; G P Fung; C B Chow; C C Shek; P M Tang; Y K Shiu; V Y H Yu
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-04-19       Impact factor: 5.747

Review 5.  Inflammatory mediators in the immunobiology of bronchopulmonary dysplasia.

Authors:  Rita M Ryan; Qadeer Ahmed; Satyan Lakshminrusimha
Journal:  Clin Rev Allergy Immunol       Date:  2008-04       Impact factor: 8.667

6.  Intrauterine growth restriction decreases pulmonary alveolar and vessel growth and causes pulmonary artery endothelial cell dysfunction in vitro in fetal sheep.

Authors:  Paul J Rozance; Gregory J Seedorf; Alicia Brown; Gates Roe; Meghan C O'Meara; Jason Gien; Jen-Ruey Tang; Steven H Abman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-08-26       Impact factor: 5.464

7.  Respiratory morbidity, healthcare utilisation and cost of care at school age related to home oxygen status.

Authors:  Anne Greenough; John Alexander; Jill Boorman; Philip A J Chetcuti; Ian Cliff; Warren Lenney; Colin Morgan; Nigel J Shaw; Karl P Sylvester; Jackie Turner
Journal:  Eur J Pediatr       Date:  2011-01-12       Impact factor: 3.183

8.  Centrifugal migration of mesenchymal cells in embryonic lung.

Authors:  Lin Shan; Meera Subramaniam; Rodica L Emanuel; Simone Degan; Pamela Johnston; Denise Tefft; David Warburton; Mary E Sunday
Journal:  Dev Dyn       Date:  2008-03       Impact factor: 3.780

9.  Mechanisms of bronchopulmonary dysplasia.

Authors:  Antonia P Popova
Journal:  J Cell Commun Signal       Date:  2013-01-20       Impact factor: 5.782

10.  Fas-ligand-induced apoptosis of respiratory epithelial cells causes disruption of postcanalicular alveolar development.

Authors:  Monique E De Paepe; Sravanthi Gundavarapu; Umadevi Tantravahi; John R Pepperell; Sheila A Haley; Francois I Luks; Quanfu Mao
Journal:  Am J Pathol       Date:  2008-06-05       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.